Alexion's 366,912 pound bone drug too expensive for Britain
0
LONDON (Reuters) - A new drug to treat a rare inherited bone disorder from Alexion Pharmaceuticals ALXN.O that costs £366,912 a year for each patient has been deemed too expensive by Britain's health cost watchdog NICE.